67 / 84
67
Spondylitis, Ankylosing OR Bechterew's Disease OR
Ankylosing Spondyloarthritis OR Rheumatoid Spondylitis OR
Marie-Struempell Disease AND (Tumor Necrosis Factor-alpha
OR golimumab OR infliximab OR adalimumab OR etanercept)
QUESTÃO 11: O uso da terapia anti-TNF é capaz
de reduzir o dano estrutural em pacientes com EA?
Spondylitis, Ankylosing OR Bechterew's Disease OR
Ankylosing Spondyloarthritis OR Rheumatoid Spondylitis OR
Marie-Struempell Disease AND (Tumor Necrosis Factor-alpha
OR golimumab OR infliximab OR adalimumab OR etanercept)
QUESTÃO 12: Existem evidências para eficácia e
segurança das drogas anti-TNF nas manifestações
extra-articulares em pacientes com EA?
(Spondylitis, Ankylosing OR Bechterew's Disease OR
Ankylosing Spondyloarthritis OR Rheumatoid Spondylitis OR
Marie-Struempell Disease) AND (Tumor Necrosis Factor-
alpha OR golimumab OR infliximab OR adalimumab OR
etanercept) AND (Uveitis OR Iridocyclitis OR Cardiovascular
Diseases OR Pulmonary Fibrosis OR Lung diseases OR Extra-
articular OR Extra articular OR Inflammatory Bowel Diseases
OR psoriatic arthritis OR Psoriasis OR Crohn Disease OR
bone)